![TFF Pharmaceuticals Inc](/common/images/company/N_TFFP.png)
The current TFFP market cap is 6.2M. The company's latest EPS is USD -6.1289 and P/E is -0.29.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 334k | 235k | 114k | 203k | 650k |
Operating Income | -5.02M | -4.42M | -5.37M | -5.79M | -3.96M |
Net Income | -5.02M | -4.41M | -4.76M | -5.75M | -4.46M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 88k | 496k | 734k |
Operating Income | -11.99M | -18.69M | -31.79M | -31.8M | -21.89M |
Net Income | -36.68M | -18.57M | -31.04M | -31.77M | -21.24M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 13.57M | 14.89M | 12.03M | 9.19M | 9.5M |
Total Liabilities | 1.29M | 1.19M | 2.46M | 3.88M | 3.62M |
Total Equity | 12.28M | 13.69M | 9.57M | 5.3M | 5.88M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 29.19M | 38.66M | 40.7M | 24.12M | 12.03M |
Total Liabilities | 1.54M | 1.32M | 1.96M | 1.24M | 2.46M |
Total Equity | 27.65M | 37.34M | 38.74M | 22.88M | 9.57M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.82M | -11.83M | -16.04M | -3.14M | -6.4M |
Investing | -36k | -48k | -95k | N/A | N/A |
Financing | -77k | 5.01M | 5.01M | 901k | 5.33M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -11.22M | -16.62M | -29.56M | -27.34M | -16.04M |
Investing | N/A | -1.1M | -869k | -1.55M | -95k |
Financing | 29.05M | 25M | 28.89M | 11.75M | 5.01M |
Market Cap | 6.2M |
Price to Earnings Ratio | -0.29 |
Price to Sales Ratio | 8.45 |
Price to Cash Ratio | 1.13 |
Price to Book Ratio | 0.65 |
Dividend Yield | - |
Shares Outstanding | 3.47M |
Average Volume (1 week) | 18.85k |
Average Volume (1 Month) | 49.22k |
52 Week Change | -81.16% |
52 Week High | 11.00 |
52 Week Low | 1.35 |
Spread (Intraday) | 0.6 (30.15%) |
Company Name | TFF Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.tffpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.